Commencement of three-month toxicology studies for BIT225 28 April 201327 November 2012 by Karen Mobbs Commencement of three-month toxicology studies for BIT225
Presentation of BIT225 Hepatitis C Virus 48-week data at AASLD conference, Boston MA 28 February 201416 November 2012 by Karen Mobbs Presentation of BIT225 Hepatitis C Virus 48-week data at AASLD conference, Boston MA
Key Phase 2 HIV/HCV trial commenced 28 April 20139 November 2012 by Karen Mobbs Key Phase 2 HIV/HCV trial commenced
Problem viruses can’t hide from new treatment — Ahead of the curve 9 September 201628 October 2012 by Karen Mobbs Problem viruses can’t hide from new treatment — Ahead of the curve, October 2012
Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting 28 April 201325 October 2012 by Karen Mobbs Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting
Annual report for the year ended 30 June 2012 3 May 201325 October 2012 by Karen Mobbs Annual report for the year ended 30 June 2012
Quarterly Report 30 September 2012 28 April 201323 October 2012 by Karen Mobbs Quarterly Report 30 September 2012
Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference 28 April 201316 October 2012 by Karen Mobbs Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference
October edition of BITNews 28 April 201311 October 2012 by Karen Mobbs October 2012 edition of BITNews